These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 902377)

  • 41. The relationship between plasma dobutamine concentrations and cardiovascular responses in cardiac failure.
    Leier CV; Unverferth DV; Kates RE
    Am J Med; 1979 Feb; 66(2):238-42. PubMed ID: 425967
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative haemodynamic effects of dobutamine and isoproterenol in man.
    Rigaud M; Boschat J; Rocha P; Ferreira A; Bardet J; Bourdarias JP
    Intensive Care Med; 1977 Aug; 3(2):57-62. PubMed ID: 893774
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Right ventricular-vascular interaction in congestive heart failure. Importance of low-frequency impedance.
    Kussmaul WG; Altschuler JA; Matthai WH; Laskey WK
    Circulation; 1993 Sep; 88(3):1010-5. PubMed ID: 8353862
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relative contribution of inotropic and vasodilator effects to amrinone-induced hemodynamic improvement in congestive heart failure.
    Konstam MA; Cohen SR; Weiland DS; Martin TT; Das D; Isner JM; Salem DN
    Am J Cardiol; 1986 Feb; 57(4):242-8. PubMed ID: 3004184
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Hemodynamic shifts in patients with congestive heart failure during treatment with sodium nitroprusside].
    Tatishvili NI; Chkhaidze ZK; Kurashvili RB; Mamatsashvili MD; Narsiia NN
    Kardiologiia; 1983 Jul; 23(7):28-31. PubMed ID: 6620808
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combined hemodynamic effects of dobutamine and IV nitroglycerin in congestive heart failure.
    Gagnon RM; Fortin L; Boucher R; Gilbert S; Morrisette M; Present S; Lemire J; David A
    Chest; 1980 Nov; 78(5):694-8. PubMed ID: 6775881
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of hemodynamic responses to nifedipine and nitroprusside in severe chronic congestive heart failure.
    Elkayam U; Weber L; Torkan B; McKay CR; Rahimtoola SH
    Am J Cardiol; 1984 May; 53(9):1321-5. PubMed ID: 6711434
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Haemodynamic effects of dobutamine in patients with coronary artery disease.
    Magnani B; Ambrosioni E; Branzi A; Picchio F; Capitanucci P
    J Int Med Res; 1977; 5(1):10-7. PubMed ID: 838109
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Afterload reduction therapy with nitroprusside in severe aortic regurgitation: improved cardiac performance and reduced regurgitant volume.
    Miller RR; Vismara LA; DeMaria AN; Salel AF; Mason DT
    Am J Cardiol; 1976 Nov; 38(5):564-7. PubMed ID: 983953
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative responses to dobutamine and nitroprusside in patients with chronic low output cardiac failure.
    Berkowitz C; McKeever L; Croke RP; Jacobs WR; Loeb HS; Gunnar RM
    Circulation; 1977 Dec; 56(6):918-24. PubMed ID: 923060
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative hemodynamic effects of intravenous dobutamine and dibutyryl cyclic AMP, a new inotropic agent, in severe congestive heart failure.
    Miyagi Y; Sasayama S; Nakajima H; Fujita M; Asanoi H
    J Cardiovasc Pharmacol; 1990 Jan; 15(1):138-43. PubMed ID: 1688971
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hemodynamic effects of dobutamine in patients below and over 65 years, with left heart failure secondary to an acute myocardial infarction.
    Renard M; Bernard R; Melot C; Jacobs P; Englert M
    Gerontology; 1984; 30(6):408-13. PubMed ID: 6519441
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
    Kieler-Jensen N; Lundin S; Ricksten SE
    J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hemodynamic effects of a new inotropic agent, piroximone (MDL 19205), in patients with chronic heart failure.
    Petein M; Levine TB; Cohn JN
    J Am Coll Cardiol; 1984 Aug; 4(2):364-71. PubMed ID: 6736478
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effects of a sodium nitroprusside-dobutamine combination in left cardiac failure].
    Moore N; Champoud O; Berland J; Cribier A; Letac B
    Therapie; 1985; 40(2):99-103. PubMed ID: 4002197
    [No Abstract]   [Full Text] [Related]  

  • 56. Assessment of vasodilator therapy in patients with severe congestive heart failure: limitations of measurements of left ventricular ejection fraction and volumes.
    Firth BG; Dehmer GJ; Markham RV; Willerson JT; Hillis LD
    Am J Cardiol; 1982 Nov; 50(5):954-9. PubMed ID: 6291370
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inotropic, vascular and neuroendocrine effects of dopexamine hydrochloride and comparison with dobutamine.
    Jaski BE; Peters C
    Am J Cardiol; 1988 Aug; 62(5):63C-67C. PubMed ID: 3407597
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of hemodynamic actions of pirbuterol and dobutamine on cardiac function in severe congestive heart failure.
    Awan NA; Needham KE; Evenson MK; Mason DT
    Am J Cardiol; 1981 Mar; 47(3):665-9. PubMed ID: 7468500
    [No Abstract]   [Full Text] [Related]  

  • 59. Hemodynamic correlates of left ventricular versus right ventricular radionuclide volumetric responses to vasodilator therapy in congestive heart failure secondary to ischemic or dilated cardiomyopathy.
    Konstam MA; Weiland DS; Conlon TP; Martin TT; Cohen SR; Eichhorn EJ; Isner JM; Zile MR; Salem DN
    Am J Cardiol; 1987 May; 59(12):1131-7. PubMed ID: 3578055
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute hemodynamic effects of piroximone (MDL 19,205) in patients with moderate congestive heart failure: comparison with sodium nitroprusside.
    Arbogast R; Brandt CM; Fincker JL; Schechter PJ
    J Cardiovasc Pharmacol; 1986; 8(1):82-9. PubMed ID: 2419699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.